Tag: PAT
Enzene launches EnzeneX™ 2.0 technology for biologics at CPHI Milan 2024
The next-generation continuous manufacturing platform aims to reduce production costs by 50%, enhancing productivity for commercial biologics
Eris Lifesciences reports 54% revenue growth in Q1 FY25
The company sees growth and synergy from recent acquisitions, with plans for further expansion in specialty and super-specialty segments
Dr Lal PathLabs records revenue of Rs 2,295.8 crore in FY24
The company has posted net profit of Rs 357.7 crores for the Financial Year ended March 31, 2024
Syngene records Rs 3,193 Crore revenue in FY23, up by 23%
Fourth quarter revenue from operations up 31% to Rs. 994 Crore and PAT up 21% to Rs. 179 Crore
Zydus Cadila’s net profit up by 41% in Q3 FY21
While the company's consolidated revenues for the quarter at Rs. 3,796 Crore, up 4% Y-o-Y, the consolidated net sales for the quarter at Rs 3754 crore up by 6% Y-o-Y....................
Syngene Q2 operations revenue stands at INR 519 Crore, up 12%...
The company posted quarterly total revenue of INR 533 Crore compared to INR 485 Crore in the corresponding quarter of last year. EBITDA for the quarter was up 6% to INR 169 Crore while PAT was up 2% to INR 84 Crore..................